ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0064

Anti-Citrullinated Protein Antibodies Arise During Affinity Maturation of Germline-Encoded Antibodies to Carbamylated Proteins in Rheumatoid Arthritis

Marta Escarra-Senmarti1, Michael Chungyoun2, Dylan Ferris1, Jeffrey Gray2 and Felipe Andrade3, 1The Johns Hopkins University School of Medicine, Baltimore, MD, 2The Johns Hopkins Whiting School of Engineering, Baltimore, MD, 3The Johns Hopkins University School of Medicine, Timonium, MD

Meeting: ACR Convergence 2024

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), Autoantibody(ies), rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The production of antibodies to modified self-antigens is a hallmark in rheumatoid arthritis (RA). Antibodies to citrullinated (ACPAs) and carbamylated proteins (CarP) are of special interest due to their high prevalence and emergence during preclinical RA. While citrullination and carbamylation generate nearly identical amino acid residues (citrulline and homocitrulline, respectively), these modifications differ significantly in biology. Arginine citrullination is a physiological process toward which immune tolerance is developed, while lysine carbamylation is environmentally driven (e.g., tobacco smoking) and thus immunogenic. How ACPAs and anti-CarP antibodies are related is unclear, but recognizing the inciting event in the production of these antibodies may shed light on the origins of RA.

Methods: RA patient-derived monoclonal ACPAs were cloned from published sequences1,2, reverted to their germline (GL) form, or mutated to change the heavy chain tryptophan residue 48 (H-W48) to methionine, and expressed in ExpiCHO cells. Control, citrullinated or carbamylated 293T cells (Fig. A) were used to test antibody reactivity to modified cellular substrates by immunoblotting. The structure of one ACPA (both original and GL sequences) bound to a citrullinated or carbamylated peptide was determined using a starting structure (crystal1 or AlphaFold2-predicted), and the Rosetta MutateResidue and FlexPepDock Protocols.

Results: E4 is an RA-derived ACPA that has been extensively studied1. Compared to control and carbamylated cells, E4 showed prominent binding to hypercitrullinated cells (Fig. B), demonstrating that citrullinated proteins are the major target of E4. When E4 was reverted to its germline form (E4GL), citrullination was no longer detected (Fig. C), indicating that reactivity to citrullinated proteins by E4 is acquired via affinity maturation. Unexpectedly, while E4 had poor recognition for CarP (Fig. B), E4GL showed prominent binding to CarP (Fig. C), implying that CarP is a primary target of E4GL. Structural analysis of E4 vs. E4GL pointed to H-W48 as a critical residue in the differential recognition of citrulline vs. homocitrulline (Fig. D). Indeed, a single change of H-W48 to methionine in E4 (E4M) shifted the antibody specificity from ACPA to anti-CarP (Fig. E). Notably, H-W48 in E4 is GL-encoded and highly conserved (either as W47 or W49) among different published ACPAs (Fig. F). Further analysis of a set of ACPAs derived from a common precursor confirmed that the GL form is specific for CarP and that the antibody transitions from anti-CarP to double positive (CarP/ACPA) to ACPA according to the pattern and number of somatic hypermutations (Fig. G, H), explaining their coexistence and diverse specificity in RA.

Conclusion: The presence of GL-encoded antibodies to CarP is explained because CarP is environmentally driven and thereby absent during B cell development. The data indicate that GL anti-CarP antibodies are the first step in the production of autoantibodies (both anti-CarP and ACPAs, via antigen-driven affinity maturation) during the development of RA (Fig. I).

References

1. Ge et al. Arthritis Rheumatol 2019, 71:210-21
2. Titcombe et al. Arthritis Rheumatol 2018, 70:1933-45

Supporting image 1

Figure. (A) Mock or PAD2/PAD4 co-expressing 293T cells were stimulated with 2 µM ionomycin to generate control and hypercitrullinated cells, respectively. 293T cells were incubated with 1M potassium cyanate to induced carbamylation. Citrullination (Cit) and carbamylation (Carb) were confirmed by AMC immunoblotting. Detection of vimentin was used as loading control. All immunoblotting assays used the same cell lysate batch and protein amount. (B,C,E,G) Lysates from control, Cit and Carb cells were tested by immunoblotting using 6.6 nM antibody E4 (B), E4GL (C), E4M (E), clade RA14 GL, 3E04, G09 and D09 (G). (D) Deduced structure of E4 (a,b) and E4GL (c,d) in complex with a citrullinated (CII-Cit_13) (a,c) or carbamylated (CII-HCit_13) (b,d) peptide from collagen II (Ref. #1). HCit, Homocitrulline. (F) Sequence alignment of heavy chain (IgH) amino acid residues 33-66 from published RA patient-derived monoclonal ACPAs. Conserved H-W48/47/49 is bold. (H) Amino acid sequence alignment of the IgH variable region of antibodies in G. The upper and lower panels depict mutation patterns and numbers, respectively. (I) B and T cells reactive to citrullinated proteins are negatively selected in mice (Yamada et al. J Immunol 2018, 201:3492-6; Dwivedi et al. Front Immunol 2017, 8:362; McElwee et al. J Exp Med 2023, 220:e20230209) and, potentially, humans. CarP-reactive naïve B cells are likely part of the normal repertoire of human B cells. Since citrulline and homocitrulline are nearly identical, the data indicate that GL-encoded anti-CarP antibodies can generate a mixture of anti-CarP, anti-CarP/ACPA and ACPAs as the result of antigen-driven affinity maturation, most likely in the context of genetic susceptibility, tobacco smoking and hypercitrullination, among other factors. This process preludes the development of RA.


Disclosures: M. Escarra-Senmarti: None; M. Chungyoun: None; D. Ferris: None; J. Gray: None; F. Andrade: Advice Connect Inspire, 2, Celgene, 9, Hillstar Bio, Inc, 2, Inova, 9.

To cite this abstract in AMA style:

Escarra-Senmarti M, Chungyoun M, Ferris D, Gray J, Andrade F. Anti-Citrullinated Protein Antibodies Arise During Affinity Maturation of Germline-Encoded Antibodies to Carbamylated Proteins in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/anti-citrullinated-protein-antibodies-arise-during-affinity-maturation-of-germline-encoded-antibodies-to-carbamylated-proteins-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anti-citrullinated-protein-antibodies-arise-during-affinity-maturation-of-germline-encoded-antibodies-to-carbamylated-proteins-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology